Corporate ActionOct 9, 2026, 05:21 PM
MAINZ BIOMED N.V. to Offer Up to $100M in Shares via At-the-Market Program
AI Summary
MAINZ BIOMED N.V., operating as Quantum Cyber N.V., has entered into a sales agreement with Titan Partners Securities LLC for an "at the market" offering program. The company intends to sell up to $100,000,000 of its ordinary shares. The net proceeds are earmarked for capital expenditures, software development, production capacity expansion, and potential strategic investments or acquisitions. The sales agent will receive a 3.0% commission on gross sales.
Key Highlights
- MAINZ BIOMED N.V. (Quantum Cyber N.V.) enters into an at-the-market offering program.
- The company plans to sell up to $100,000,000 of its ordinary shares.
- Proceeds will fund capital expenditures, software development, and production capacity expansion.
- Funds may also be used for potential acquisitions, investments, strategic partnerships, or joint ventures.
- The company will pay Titan Partners Securities LLC a commission of 3.0% of gross sales.
- The offering will terminate upon the sale of all shares or termination of the sales agreement.
Price Impact
More from QUCY